Comparative Effectiveness of Medical Therapy, Supervised Exercise, and Revascularization for Patients with Intermittent Claudication: A Network Meta-analysis

Clinical Cardiology

Volumn 38, Issue 6, 2015, Pages 378-386

  Vemulapalli, Sreekanth ^a,b   Dolor, Rowena J ^a,b   Hasselblad, Vic ^c   Subherwal, Sumeet ^b   Schmit, Kristine M ^c   Heidenfelder, Brooke L ^b   Patel, Manesh R ^a,b   Jones, W Schuyler ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; PENTOXIFYLLINE; ANTITHROMBOCYTIC AGENT; TETRAZOLE DERIVATIVE;

ANKLE BRACHIAL INDEX; ARTICLE; CLAUDICATION; CLINICAL EFFECTIVENESS; EXERCISE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; INTERMITTENT CLAUDICATION; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY OF LIFE; QUESTIONNAIRE; REVASCULARIZATION; SHORT FORM 36; SYSTEMATIC REVIEW; WALKING; ADOLESCENT; ADULT; AGED; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; KINESIOTHERAPY; LOWER LIMB; META ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE EFFECTIVENESS RESEARCH; EXERCISE THERAPY; HUMANS; INTERMITTENT CLAUDICATION; LOWER EXTREMITY; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; QUALITY OF LIFE; TETRAZOLES; WALKING; YOUNG ADULT;

EID: 84931956590     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22406     Document Type: Article

References (16)

1. Ouriel K., Peripheral arterial disease. Lancet. 2001; 358: 1257-1264.
2. Mahoney EM, Wang K, Keo HH, et al,; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes. 2010; 3: 642-651.
3. Feinglass J, McCarthy WJ, Slavensky R, et al,; The Chicago Claudication Outcomes Research Group. Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. J Vasc Surg. 1996; 24: 503-512.
4. McDermott MM, Greenland P, Liu K, et al., Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286: 1599-1606.
5. Rooke TW, Hirsch AT, Misra S, et al., 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol. 2011; 58: 2020-2045.
6. Ahimastos AA, Pappas EP, Buttner PG, et al., A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication [provisional abstract]. J Vasc Surg. 2011; 54: 1511-1521.
7. Murphy TP, Cutlip DE, Regensteiner JG, et al,; CLEVER Study Investigators. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) study. Circulation. 2012; 125: 130-139.
8. Jones WS, Schmit KM, Vemulapalli S, et al., Treatment Strategies for Patients With Peripheral Artery Disease. Comparative Effectiveness Review No. 118. AHRQ publication 13-EHC090-EF (prepared by the Duke Evidence-based Practice Center under contract no. 290-2007-10066-I). http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1518. Published May 2013. Accessed November 1, 2014.
9. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; January 2014 (update). http://www.effectivehealthcare.ahrq.gov/ehc/products/60/318/CER-Methods-Guide-140109.pdf. Accessed March 16, 2012.
10. Cohen J., Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: L. Erlbaum Associates; 1988.
11. Leng GC, Fowler B, Ernst E,. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2000; 2:CD000990.
12. Watson L, Ellis B, Leng GC,. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008; 4:CD000990.
13. Robless P, Mikhailidis DP, Stansby GP,. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008; 1:CD003748.
14. National Institute for Health and Clinical Excellence. Lower Limb Peripheral Arterial Disease: Diagnosis and Management. NICE Clinical Guideline. http://www.nice.org.uk/guidance/cg147. Published August 2012. Accessed February 13, 2015.
15. Cipriani A, Higgins JP, Geddes JR, et al., Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013; 159: 130-137.
16. Hirsch AT, Haskal ZJ, Hertzer NR, et al., ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113: e463-e654.